The Change of Antituberculosis Drug Resistance Rate in Edirne Region in 1996 and 2006

Basit Öğe Kaydı
dc.authoridOzdemir, Levent/0000-0002-3478-5454
dc.authoridÖZDEMİR, LEVENT/0000-0003-4578-9247
dc.authorwosidOzdemir, Levent/AEV-9509-2022
dc.authorwosidÖZDEMİR, LEVENT/HJP-5498-2023
dc.contributor.authorPerincek, Gokhan
dc.contributor.authorTabakoglu, Erhan
dc.contributor.authorOtkun, Metin
dc.contributor.authorOzdemir, Levent
dc.date.accessioned2024-06-12T10:52:10Z
dc.date.available2024-06-12T10:52:10Z
dc.date.issued2010
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective: To establish the change in the ratio of the a ntituherculosis drug resistance in Edirne region between 1996-2006. Materials and Methods: The patients, who were detected with Mycobacterium tuberculosis proliferation in the cultures, were enrolled to the study between 1996-2006. The patients, who were diagnosed with isoniazid, rifampisin, ethambutol, streptomycin and multi-drug resistance were selected and their data of was uploaded to SPSS software in order to perform statistical analysis. Results: We found the Mycobacterium tuberculosis proliferation of cultures in 70 patients in 1996, whew. 21 patients had isoniazid, 8 patients had rifampicin, 7 patients had ethambutol, r patients had streptomycin, and 5 patients had multi Burg resistance. En 2006, illyrobacterium tuberculosis proliferation was established in 47 patients. Of these, 11 patients had isoniazid, 8 had rifampisin, one patient had ethambutol, 2 patients had streptomycin and 3 patients had multi-durg resistance. We compared the changes in the resistance figures and found a decrease: of drug resistance as follows: in isoniazid, from 21 patients (301Y0) to 11 patients (23.4%); in rifampisin, from 8 patients (11%) to 4 patients (8.5%0; in ethambutol, from 7 patients (13'Yo) to one patient (2.1`,0; in streptomycin, from r patients (39%) to 2 patients (4.3%); in multi drug, from 5 patients (7%) to 3 patients (6.4`%). Conclusion: Although statistically significant decrease of drug resistance was not found in isoniazid, rifampisin, ethambutol and multi-drug, a significant drug resistance \vas estabished in streptomycin in Edirne region during the 10 years period.en_US
dc.identifier.endpage133en_US
dc.identifier.issn2148-3620
dc.identifier.issn2148-5402
dc.identifier.issue3en_US
dc.identifier.startpage129en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/18602
dc.identifier.volume12en_US
dc.identifier.wosWOS:000421868500005en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isotren_US
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.ispartofEurasian Journal Of Pulmonologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntituberculosis Drugs Resistanceen_US
dc.subjectMycobacterium Tuberculosis Complexen_US
dc.subjectTuberculosisen_US
dc.titleThe Change of Antituberculosis Drug Resistance Rate in Edirne Region in 1996 and 2006en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu